| scholarly article | Q13442814 |
| P2093 | author name string | Rakesh Kumar | |
| Arvind Kumar | |||
| Arun Malhotra | |||
| Tarun Jindal | |||
| Monika Meena | |||
| Roman Dutta | |||
| Balasubramanian Venkitaraman | |||
| P2860 | cites work | Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data | Q30666654 |
| Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature | Q34278313 | ||
| Bronchial carcinoid tumors: surgical management and long-term outcome. | Q34518093 | ||
| The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules | Q36705852 | ||
| A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors | Q43243195 | ||
| False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications | Q44853250 | ||
| Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging | Q45106375 | ||
| Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose | Q48254068 | ||
| 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT | Q57757715 | ||
| Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy | Q60652391 | ||
| Treatment and prognosis in bronchial carcinoids involving regional lymph nodes | Q72714075 | ||
| Evaluation of primary pulmonary carcinoid tumors using FDG PET | Q74515559 | ||
| Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications | Q80195199 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography | Q130273251 |
| P304 | page(s) | 70-75 | |
| P577 | publication date | 2011-06-15 | |
| P1433 | published in | Cancer Imaging | Q2577267 |
| P1476 | title | Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids | |
| P478 | volume | 11 |
| Q38082417 | 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type |
| Q50059402 | Endobronchial Treatment for Bronchial Carcinoid: Patient Selection and Predictors of Outcome. |
| Q58005292 | Evolving role of PET/CT with different tracers in the evaluation of pulmonary neuroendocrine tumours |
| Q37427631 | Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung. |
| Q43218520 | Nuclear oncology in Cancer Imaging 2011. |
| Q59074896 | PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors |
| Q38213643 | PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. |
| Q37592451 | PET/CT imaging of neuroendocrine tumors with (68)Gallium-labeled somatostatin analogues: An overview and single institutional experience from India |
| Q94156367 | POSTER PRESENTATIONS |
| Q94230866 | POSTER PRESENTATIONS |
| Q51167759 | Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. |
| Q36149338 | Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids |
| Q48206758 | Surgical Resection for Pulmonary Carcinoid: Long-Term Results of Multicentric Study-The Importance of Pathological N Status, More Than We Thought |
| Q64116382 | The utility of 18F-FDG and 68Ga-DOTA-Peptide PET/CT in the evaluation of primary pulmonary carcinoid: A systematic review and meta-analysis |
Search more.